CK Life Sciences Intl (Holdings) Inc
HKEX:775

Watchlist Manager
CK Life Sciences Intl (Holdings) Inc Logo
CK Life Sciences Intl (Holdings) Inc
HKEX:775
Watchlist
Price: 0.84 HKD 2.44% Market Closed
Market Cap: 8.1B HKD

CK Life Sciences Intl (Holdings) Inc
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

CK Life Sciences Intl (Holdings) Inc
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
CK Life Sciences Intl (Holdings) Inc
HKEX:775
Cash from Operating Activities
HK$202.1m
CAGR 3-Years
-31%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
H
Hbm Holdings Ltd
HKEX:2142
Cash from Operating Activities
$30.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
China Regenerative Medicine International Ltd
HKEX:8158
Cash from Operating Activities
HK$3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Uni-Bio Science Group Ltd
HKEX:690
Cash from Operating Activities
HK$70.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Essex Bio-Technology Ltd
HKEX:1061
Cash from Operating Activities
HK$359.3m
CAGR 3-Years
-6%
CAGR 5-Years
12%
CAGR 10-Years
N/A
No Stocks Found

CK Life Sciences Intl (Holdings) Inc
Glance View

Market Cap
8.1B HKD
Industry
Biotechnology

CK Life Sciences International (Holdings), Inc. operates as an investment company, which engages in the business of research and development, manufacturing, commercialization, marketing and selling of products and assets in nutraceuticals, pharmaceuticals and agriculture related business. The company employs 1,855 full-time employees The company went IPO on 2002-07-16. The firm operates through three segments. The Health segment is engaged in the development, production, marketing and sales of healthcare and pharmaceutical products. The healthcare brands under the Company include Lipa, Vitaquest and Sante Naturelle, among others. Its pharmaceutical products include cancer-related pharmaceuticals and painkillers, among others. The Agriculture-related Businesses segment is engaged in the operation of vineyards, as well as the development, production, marketing and sales of agriculture and related products. Its agricultural products include fertilizers and crop protection products, among others. The Investment segment is engaged in the investment in financial and investment products.

Intrinsic Value
0.7 HKD
Overvaluation 17%
Intrinsic Value
Price

See Also

What is CK Life Sciences Intl (Holdings) Inc's Cash from Operating Activities?
Cash from Operating Activities
202.1m HKD

Based on the financial report for Jun 30, 2025, CK Life Sciences Intl (Holdings) Inc's Cash from Operating Activities amounts to 202.1m HKD.

What is CK Life Sciences Intl (Holdings) Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-10%

Over the last year, the Cash from Operating Activities growth was -65%. The average annual Cash from Operating Activities growth rates for CK Life Sciences Intl (Holdings) Inc have been -31% over the past three years , -10% over the past five years .

Back to Top